Corporate Communications:
Dr. Lise Hébert
(450) 680-4500
Toll free (877) 680-4500

If you need additional assistance or information regarding the company, please send an Email to: webinfo@neurochem.com.

December 16, 1998

- NRC and Neurochem to Collaborate on Alzheimer's Disease Research.

Neurochem Inc. (TSX : NRM) and The National Research Council (NRC) today announced a collaborative research agreement to identify potential therapeutics for Alzheimer's disease (AD). In the alliance ...

November 17, 1997

- APPOINTMENT NOTICE - Dr. Francine Gervais, Vice-President, Research & Development.

Neurochem Inc. (TSX : NRM) Dr. Louis R. Lamontagne, President & CEO of Neurochem Inc., is pleased to announce the appointment of Dr. Francine Gervais to the position of Vice-President, Research and Development. ...

November 17, 1997

- APPOINTMENT NOTICE - Dr. Denis Garceau, Vice-President, Drug Development.

Neurochem Inc. (TSX : NRM) Dr. Louis R. Lamontagne, President & CEO of Neurochem Inc., is pleased to announce the appointment of Dr. Denis Garceau to the position of Vice-President, Drug Development. ...

November 28, 1996

- Neurochem Signs Collaborative Research Agreement to Discover Anti-Amyloid Compounds with Warner-Lambert Parke-Davis.

Neurochem Inc. (TSX : NRM) and Warner-Lambert Company (NYSE: WLA) have announced that they have signed an agreement to collaborate on research for the discovery of compounds that ...

October 7, 1996

- Neurochem Completes $14M financing Impetus for Development of Alzheimer's and Diabetes Drugs.

Neurochem Inc. (TSX : NRM) has announced the completion of a $14 million financing arrangement with a group of leading biotech venture capital investors. The size of the agreement, one of Canada's ...

September, 1996

- Neurochem Inc. is pleased to announce the Successful Completion of a Private Placement Totaling $10.2M.

Neurochem Inc. (TSX : NRM) The investors consist of Neurochem's previous financial partners - Quorum Growth Inc. (Toronto), one of Canada's leading providers of venture capital and strategic ...

Our site is best viewed with IE4+ at a resolution of 1024×768.
All contents copyright © 1998-2007 Neurochem Inc.
Terms, Conditions and Legal Notice.